Caplin Point Laboratories Limited

BSE:524742 Stok Raporu

Piyasa değeri: ₹158.1b

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Caplin Point Laboratories Gelecekteki Büyüme

Future kriter kontrolleri 2/6

Caplin Point Laboratories is forecast to grow earnings and revenue by 14.8% and 13.7% per annum respectively. EPS is expected to grow by 14.8% per annum. Return on equity is forecast to be 18.4% in 3 years.

Anahtar bilgiler

14.8%

Kazanç büyüme oranı

14.8%

EPS büyüme oranı

Pharmaceuticals kazanç büyümesi18.1%
Gelir büyüme oranı13.7%
Gelecekteki özkaynak getirisi18.4%
Analist kapsamı

Low

Son güncelleme10 Sep 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Kazanç ve Gelir Büyüme Tahminleri

BSE:524742 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (INR Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
3/31/202725,6867,190N/AN/A2
3/31/202622,1405,9203,796N/A3
3/31/202519,3495,1473,504N/A3
6/30/202417,5774,776N/AN/AN/A
3/31/202416,9614,5711,7263,184N/A
12/31/202316,3184,376N/AN/AN/A
9/30/202315,6834,1793992,593N/A
6/30/202315,1573,947N/AN/AN/A
3/31/202314,6833,7637792,714N/A
12/31/202214,1823,532N/AN/AN/A
9/30/202213,7243,3072,3053,467N/A
6/30/202213,1533,140N/AN/AN/A
3/31/202212,7102,9982,4563,367N/A
12/31/202112,0992,872N/AN/AN/A
9/30/202111,5812,7671,2882,044N/A
6/30/202111,2172,586N/AN/AN/A
3/31/202110,6242,4231,9532,686N/A
12/31/20209,9862,248N/AN/AN/A
9/30/20209,5242,1891,6501,877N/A
6/30/20209,1072,193N/AN/AN/A
3/31/20208,6402,150-321447N/A
12/31/20198,3562,159N/AN/AN/A
9/30/20197,6642,032-331830N/A
6/30/20196,9481,894N/AN/AN/A
3/31/20196,4901,766182834N/A
12/31/20186,0481,621N/AN/AN/A
9/30/20185,8741,538N/AN/AN/A
6/30/20185,6281,459N/AN/AN/A
3/31/20185,3991,448N/A665N/A
12/31/20175,1451,430N/AN/AN/A
9/30/20174,7571,297N/AN/AN/A
6/30/20174,4011,165N/AN/AN/A
3/31/20174,016956N/A676N/A
12/31/20163,655783N/AN/AN/A
9/30/20163,420703N/AN/AN/A
6/30/20163,238619N/AN/AN/A
3/31/20163,088584N/A565N/A
12/31/20152,906535N/AN/AN/A
9/30/20152,722465N/AN/AN/A
6/30/20152,518410N/A499N/A
3/31/20152,296353N/AN/AN/A
12/31/20142,074318N/AN/AN/A
9/30/20141,893305N/AN/AN/A
6/30/20141,731258N/A598N/A
3/31/20141,643204N/AN/AN/A
12/31/20131,517167N/AN/AN/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 524742's forecast earnings growth (14.8% per year) is above the savings rate (6.7%).

Kazançlar ve Piyasa: 524742's earnings (14.8% per year) are forecast to grow slower than the Indian market (17.2% per year).

Yüksek Büyüme Kazançları: 524742's earnings are forecast to grow, but not significantly.

Gelir ve Pazar: 524742's revenue (13.7% per year) is forecast to grow faster than the Indian market (10.1% per year).

Yüksek Büyüme Geliri: 524742's revenue (13.7% per year) is forecast to grow slower than 20% per year.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 524742's Return on Equity is forecast to be low in 3 years time (18.4%).

Büyüyen şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y